首页> 外文期刊>Nefrologia >Hydration status and blood pressure variability in primary hypertensive patients
【24h】

Hydration status and blood pressure variability in primary hypertensive patients

机译:原发性高血压患者的水合状态和血压变异性

获取原文
           

摘要

BackgroundIncreased blood pressure variability (BPV) is associated with higher cardiovascular risk. The association between BPV and fluid status in hypertensive patients has not been investigated so far. The aim of the present study was to determine the contribution of fluid balance to BPV and impact on endothelial and cardiac functions among primary hypertensive patients.MethodsThis is a prospective interventional study conducted in primary hypertensive patients with one-year follow-up. Volume status measurements by a body composition monitor, ambulatory blood pressure (BP) monitoring, echocardiographic and carotid intima-media thickness (CIMT) measurements were performed at enrollment and at twelfth. Patients in one of the two groups were kept negative hydrated during trial with diuretic treatment. Patients in other group were positively hydrated (hypervolemic) at enrollment, antihypertensive drugs other than diuretics (vasodilator agents) were added or intensified according to the BP monitoring. Average real variability (ARV) index was used for establishing the prognostic significance of BPV.ResultsThe study population consisted of 50 patients with a mean age of 54.5±8.8 years. At the end of one-year follow-up, patients in negative hydrated group were found to have significantly lower BP, CIMT, left ventricle mass index (LVMI) and systolic and diastolic ARV. More weight gain and higher systolic BP were major risk factors of high systolic ARV. Patients who have improvement in CIMT and LVMI were considered as target organ damage (TOD) recovery present. In negatively hydrated group, TOD significantly reduced during trial. In patients who have TOD recovery, BPV significantly more reduced like systolic and diastolic BP. Significant risk factors associated with the presence of TOD were 24h systolic BP and daytime and night time diastolic ARV and night time diastolic BP.ConclusionAddition of diuretic to established treatment or intensified diuretic treatment and keeping patients in negative hydration status resulted in reduction in BPV at twelfth month of follow-up. More weight gain and higher systolic BP are major risk factors of high systolic ARV, but not hypervolemia. BPV, especially diastolic ARV, was significantly associated with TOD.
机译:背景上血压变异性(BPV)与较高的心血管风险有关。到目前为止,尚未调查高血压患者的BPV和流体状态之间的关联。本研究的目的是确定流体平衡对BPV的贡献,以及对原发性高血压患者中内皮和心脏功能的影响。方法是在原发性高血压患者中进行的一项前瞻性介入研究,有一年的随访。体积状态测量由身体成分监测器,动态血压(BP)监测,超声心动图和颈动脉内膜内膜介质厚度(CIMT)测量在注册和第十二处进行。在试验期间,两组中的一组中的患者在试验期间保持阴性水合。在其他组患者在注册时呈正水合(超血剂),根据BP监测加入或加强除利尿剂(血管扩张剂)以外的抗高血压药物。平均真实变异性(ARV)指数用于建立BPV.Resultshe的预后意义,由50名患者组成,平均年龄为54.5±8.8岁。在一年的随访结束时,发现负水合组的患者有明显降低Bp,CIMT,左心室质量指数(LVMI)和收缩性和舒张型ARV。更多体重增加和更高的收缩压BP是高收缩期的主要危险因素。具有改善CIMT和LVMI的患者被视为目标器官损伤(TOD)恢复。在负水性基团中,试验期间的TOD显着减少。在患有TOD恢复的患者中,BPV均像收缩性和舒张性BP一样减少。与TOD的存在相关的重大风险因素是24h收缩压BP和白天和夜间时间舒张性ARV和夜间舒张性BP。利尿剂的组合加入治疗或加强利尿处理,并保持负水合状态的患者导致BPV在第十二次降低BPV一个月的后续行动。更多体重增加和更高的收缩压BP是高收缩期ARV的主要危险因素,但不具有高血度血症。 BPV,尤其是舒张性ARV,与TOD显着相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号